| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 01/25/2007 | CA2612468A1 4,5-dihydr0-1h-pyrazole derivatives, their preparation and use as medicaments |
| 01/25/2007 | CA2611364A1 Indoline-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 01/25/2007 | CA2609319A1 Thiophene compounds and thrombopoietin receptor activators |
| 01/24/2007 | EP1745041A2 Quinoxaline inhibitors of the hedgehog signalling pathway |
| 01/24/2007 | EP1745032A2 Cxcr1 and cxcr2 chemokine antagonists |
| 01/24/2007 | EP1745009A1 Heteroaryl substituted cyclohexyl-1,4-diamine derivatives |
| 01/24/2007 | EP1745002A1 Novel compounds, their preparation and use |
| 01/24/2007 | EP1423100B1 Plaster comprising sertaconazole for the treatment of dysfunctions and disorders of nails |
| 01/24/2007 | EP1377555B1 A dioxino[2,3-g]quinoline-9-carboxylic acid derivative as nk3 receptor antagonist |
| 01/24/2007 | EP1363900B1 Isoindole-imide compounds, compositions and uses thereof |
| 01/24/2007 | EP0968206B8 N-heterocyclic derivatives as nos inhibitors |
| 01/24/2007 | CN1902195A Modulators of cellular adhesion |
| 01/24/2007 | CN1902186A Thiazole and pyrazole derivatives as FLT-3 kinase inhibitors |
| 01/24/2007 | CN1902181A Benzimidazoles useful as modulators of ion channels |
| 01/24/2007 | CN1902179A Methods and compositions for selectin inhibition |
| 01/24/2007 | CN1902177A Novel piperidine derivative |
| 01/24/2007 | CN1902172A N-acylated-3- (benzoyl) - pyrrolidines as 11-beta-hsd1 inhibitors useful for the treatment of metabolic disorders |
| 01/24/2007 | CN1902168A Novel1,3-disubstituted azetidine derivatives for use as 5ht2a receptor ligands |
| 01/24/2007 | CN1901971A Cyclopropane compounds and pharmaceutical use thereof |
| 01/24/2007 | CN1901917A (3-oxo-3, 4-dihydro-quinoxalin-2-yl-amino) -benzamide derivatives and related compound as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity |
| 01/24/2007 | CN1901912A Preparation of pharmaceutical salts of [1, 4] - bipiperidine |
| 01/24/2007 | CN1901910A Substituted piperidines for the treatment of metabolic syndrome |
| 01/24/2007 | CN1296371C Photochromic bis-naphthopyran compounds |
| 01/24/2007 | CN1296368C Benzothiophenes as adenosine receptor regulating agent |
| 01/24/2007 | CN1296357C Heteroaryl-substituted aminocyclohexane derivatives |
| 01/24/2007 | CN1296354C Pharmaceutically active pyrrolidine derivatives as BAX inhibitors |
| 01/23/2007 | US7166726 Aryl substituted 3,4-dihydroanthracene derivatives having retinoid antagonist or retinoid inverse agonist type biological activity |
| 01/23/2007 | US7166659 Substituted 5-aryl-2-(2-hydroxyphenyl)-2H-benzotriazole UV absorbers, compositions stabilized therewith and process for preparation thereof |
| 01/23/2007 | US7166629 Aminoindazole derivatives as medicaments and pharmaceutical compositions including them |
| 01/23/2007 | US7166619 Compounds for treatment of diseases associated with prenylation of proteins |
| 01/23/2007 | US7166617 Cyclic amide derivatives |
| 01/23/2007 | US7166614 CCR-2 modulators; INFLAMMATORY, IMMUNOREGULATORY, ALLERGIC, AND AUTOIMMUNE DISORDERS AND DISEASES |
| 01/23/2007 | US7166609 Osteoarthritis; periodontal disease; antiarthritic agents |
| 01/23/2007 | US7166598 Piperazine derivatives |
| 01/23/2007 | US7166587 Gamma -secretase inhibitors; for treatment of Alzheimer's disease; e.g 2,3-difluoro-benzyl)-carbamic acid (S)-1-(5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-ylcarbamoyl)-ethyl ester |
| 01/23/2007 | US7166586 Sulfonamide lactam inhibitors of FXa and method |
| 01/23/2007 | US7166368 A platinum complexes containing a 2,4-pentanedionate group and pyridyl group, maxima spectral emittance |
| 01/23/2007 | CA2338311C Prodrugs of the pyridyl methyl sulfinyl benzimidazoles |
| 01/23/2007 | CA2239968C Pyrimidine derivatives and guanine derivatives, and their use in treating tumour cells |
| 01/18/2007 | WO2007008895A1 Kinase inhibitors |
| 01/18/2007 | WO2007008143A1 Heterocyclic sulfonamide derivatives as inhibitors of factor xa |
| 01/18/2007 | WO2007007910A1 Heterocycle-substituted benzimidazole derivative |
| 01/18/2007 | WO2007007588A1 Compound having cyclic group with planarity as core |
| 01/18/2007 | WO2007006928A1 N-[(4,5-diphenylpyrimidin-2-yl)methyl]amine derivatives, the preparation thereof and their therapeutic use |
| 01/18/2007 | WO2007006926A2 Novel 2,4-dianilinopyrimidine derivatives, the preparation thereof, their use as medicaments, pharmaceutical compositions and, in particular, as ikk inhibitors |
| 01/18/2007 | WO2007006739A1 Benzoheterocyclylethylcarboxamide derivatives |
| 01/18/2007 | WO2007006594A2 Reactive azo dyes, methods for the production thereof and their use |
| 01/18/2007 | WO2007006546A1 Amide derivatives as kinase inhibitors |
| 01/18/2007 | WO2007006534A2 Piperidine derivatives useful in the diagnostic and therapeutic treatment of diseases depending on renin activity |
| 01/18/2007 | WO2006113140A3 Novel compounds useful for bradykinin b1 receptor antagonism |
| 01/18/2007 | WO2006100635A3 Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists |
| 01/18/2007 | WO2005070893A3 Azadecalin glucocorticoid receptor modulators |
| 01/18/2007 | US20070015819 Novel compounds |
| 01/18/2007 | US20070015799 Glyoxalase inhibitors |
| 01/18/2007 | US20070015788 N-(3-Aryl-3-substitutedphenylpropyl) piperidines or 8-azabicyclo[3.2.1]octanes that are additionally substituted with an optionally fused 5-member N-heterocycle; the compounds are modulators of CCR5 receptor activity and are used in treating diseases such as rheumatoid arthritis |
| 01/18/2007 | US20070015774 Quinazoline derivatives useful in cancer treatment |
| 01/18/2007 | US20070015755 Novel compounds and compositions as protease inhibitors |
| 01/18/2007 | US20070015730 [4-(tert-butyldimethylsilanyloxy)-3-oxobutyl]methylcarbamic acid tert-butyl ester; (R)-6,8-difluoro-3,4-dihydro-2H-1-benzopyran-3-amine; for the treatment of cardiovascular disorders such as hypertension and chronic heart failure |
| 01/18/2007 | US20070015664 2,4,6-Phenyl substituted cyclic ketoenols |
| 01/18/2007 | CA2614691A1 Piperidine derivatives useful in the diagnostic and therapeutic treatment of diseases depending on renin activity |
| 01/18/2007 | CA2614597A1 Novel 2,4-dianilinopyrimidine derivatives, the preparation thereof, their use as medicaments, pharmaceutical compositions and, in particular, as ikk inhibitors |
| 01/18/2007 | CA2614544A1 Heterocycle-substituted benzimidazole derivative |
| 01/18/2007 | CA2602389A1 Kinase inhibitors |
| 01/17/2007 | EP1743894A1 Heterocyclyl-substituted pyrazoline compounds, their preparation and use as medicaments |
| 01/17/2007 | EP1743890A1 4,5-Dihydro-1H-pyrazole derivatives, their preparation and use as medicaments |
| 01/17/2007 | EP1743885A2 TNF-Alpha Produktion Hemmer zur Behandlung von Autoimmunerkrankungen |
| 01/17/2007 | EP1742935A1 Polycyclic pyrazines as potassium ion channel modulators |
| 01/17/2007 | EP1742927A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof |
| 01/17/2007 | EP1742925A1 Substituted 5, 6, 7, 8-tetrahydro-pyrido[4, 3-d]pyrimidine-2-yl compounds and 5, 6, 7, 8-tetrahydro-quinazoline-2-yl compounds |
| 01/17/2007 | EP1742913A1 Inhibitors of hepatitis c virus ns3/ns4a serine protease |
| 01/17/2007 | EP1742906A2 Non-linear optically active molecules, their synthesis, and use |
| 01/17/2007 | EP1742634A1 Polycyclic pyrimidines as potassium ion channel modulators |
| 01/17/2007 | EP1400518B1 Heterocyclic compound derivatives and medicines |
| 01/17/2007 | EP1383751B1 Novel azoles having an insecticidal action |
| 01/17/2007 | EP1268444B1 2,4-di(hetero-)arylamino(-oxy)-5-substituted pyrmidines as antineoplastic agents |
| 01/17/2007 | CN1898210A 2-pyridinylethylcarboxamide derivatives and their use as fungicides |
| 01/17/2007 | CN1898209A Pyridine carboxylic acid derivatives as glucokinase modulators |
| 01/17/2007 | CN1898205A Indolinone derivatives and their use in treating disease-states such as cancer |
| 01/17/2007 | CN1897944A Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity |
| 01/17/2007 | CN1896084A Non-sedating barbituric acid derivatives |
| 01/17/2007 | CN1896070A 2- and 2,5-substituted phenylketo-enols |
| 01/17/2007 | CN1295217C New asymmetric diaryl-methylamine intermediates for the preparation of diarylmethylpiperazines derivatives |
| 01/17/2007 | CN1295216C Molindone derivatives and use for preparing antineoplastic medicine thereof |
| 01/16/2007 | US7164024 Muscarinic acetylcholine receptor antagonist; Parkinson's disease; dystonia; analgesics; irritable bowel syndrome |
| 01/16/2007 | US7163954 Substituted naphthyl benzothiophene acids |
| 01/16/2007 | US7163943 e.g., 6-(3-Chloro-4-methoxy-phenoxy)-N-cycloheptyl-N'-methyl-N'-(1-methyl-piperidin-4-yl)-[1,3 ,5]triazine-2,4-diamine; inhibit or block glycated protein produced induction of the signaling-associated inflammatory response in endothelial cells and inhibit smooth muscle proliferation. |
| 01/16/2007 | US7163937 Cyclic derivatives as modulators of chemokine receptor activity |
| 01/16/2007 | CA2219742C N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists |
| 01/11/2007 | WO2007005673A1 Pyrimidine-substituted benzimidazole derivatives as protein kinase inhibitors |
| 01/11/2007 | WO2007005668A2 Bis-aryl kinase inhibitors and their use in the treatment of inflammation, angiogenesis and cancer |
| 01/11/2007 | WO2007005404A1 AMINO-5-(6-MEMBERED)HETEROARYLIMIDAZOLONE COMPOUNDS AND THE USE THEREOF FOR ß-SECRETASE MODULATION |
| 01/11/2007 | WO2007005366A1 AMlNO-5-(5-MEMBERED)HETEROARYLIMIDAZOLONE COMPOUNDS AND THE USE THEREOF FOR β-SECRETASE MODULATION |
| 01/11/2007 | WO2007004959A1 New compounds, process for their preparation, intermediates, pharmaceutical compositions and their use in the treatment of 5-ht6 mediated disorders such as alzheimer's disease, cognitive disorders, cognitive impairment associated with schizophrenia, obesity and parkinson's disease |
| 01/11/2007 | WO2007003934A2 17beta-hydr0xyster0id dehydrogenase type 3 (17beta-hsd3 ) inhibitors |
| 01/11/2007 | WO2007003536A1 Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect |
| 01/11/2007 | WO2006009734A8 Gonadotropin releasing hormone receptor antagonists |
| 01/11/2007 | US20070010671 Novel quinazoline derivatives and methods of treatment related to the use thereof |
| 01/11/2007 | US20070010562 Nr1h4 nuclear receptor binding compounds |
| 01/11/2007 | US20070010561 Prenylation inhibitors and methods of their synthesis and use |
| 01/11/2007 | US20070010559 Indole derivatives for use as chemical uncoupler |